Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
CD46 is a cellular receptor for species D human adenovirus
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi.
Institute for Vaccine Research and Development, Hokkaido University, Hokkaido, Japan.
Visa övriga samt affilieringar
2025 (Engelska)Ingår i: mBio, ISSN 2161-2129, E-ISSN 2150-7511, Vol. 16, nr 11, artikel-id e0158725Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Human adenovirus species D (HAdV-D) contains two-thirds of all known HAdV types (116 in total) and is important as a vector in clinical applications. However, the broad tropism exhibited by several HAdV-D types poses challenges for their use as targeted gene delivery vectors. Since adenoviral tropism is largely governed by receptor usage, we aimed to determine the relative importance of known adenovirus receptors in mediating infection by different HAdV-D types. Here, we generated A549 single-cell CRISPR/Cas9 knockout clones of desmoglein 2 (DSG2), CD46, the coxsackievirus and adenovirus receptor (CAR), and cytidine monophosphate N-acetylneuraminic acid synthetase (CMAS; needed for biosynthesis of sialic acid-containing glycans), and assessed their relative importance for infection by 18 different HAdV-D types. We show that CD46 is the most important receptor for a majority of species D HAdVs. Minor changes in infection levels were noted with A549-ΔCAR and A549-ΔDSG2 cells, whereas A549-ΔCMAS cells displayed an increased susceptibility to infection. We proceed to show that HAdV-D types require CD46 for efficient attachment to A549 cells, and surface plasmon resonance analysis demonstrates that their hexon proteins bind CD46 in an avidity-dependent manner. Strategies to retarget HAdV-D vectors should thus consider hexon-CD46 interactions as a critical determinant of tropism, as CD46 is broadly expressed in vivo. These results increase our understanding of adenovirus-host interactions and will guide the development and targeting of vectors based on HAdV-D types. IMPORTANCE: Several human adenovirus species D (HAdV-D) types are currently used, or under development, as viral vectors for vaccines and gene delivery. However, the unusually broad tropism observed in many HAdV-D types limits their specificity and effectiveness as targeted vectors. Since tropism is largely governed by receptor usage, and previous studies have reported conflicting findings on receptor preferences within this species, clarifying receptor usage is essential. In this study, we systematically investigated receptor usage in 18 different HAdV-D types and identified CD46 as the primary receptor. Since CD46 is widely expressed across human tissues, our findings explain the broad cellular tropism of these viruses and provide valuable insight for the rational design and refinement of HAdV-D-based vectors.

Ort, förlag, år, upplaga, sidor
American Society for Microbiology, 2025. Vol. 16, nr 11, artikel-id e0158725
Nyckelord [en]
adenovirus, CD46, receptor-ligand interaction, vector biology, virus-host interactions
Nationell ämneskategori
Mikrobiologi inom det medicinska området Medicinsk bioteknologi (Inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)
Identifikatorer
URN: urn:nbn:se:umu:diva-246785DOI: 10.1128/mbio.01587-25ISI: 001575516100001PubMedID: 40980888Scopus ID: 2-s2.0-105021474222OAI: oai:DiVA.org:umu-246785DiVA, id: diva2:2016737
Forskningsfinansiär
Vetenskapsrådet, 2023-01831Vetenskapsrådet, 2019-01472Cancerfonden, 22 2005 PjCancerfonden, CAN 2018/771EU, Horisont Europa, 101098647Tillgänglig från: 2025-11-26 Skapad: 2025-11-26 Senast uppdaterad: 2025-11-26Bibliografiskt granskad

Open Access i DiVA

fulltext(1039 kB)63 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1039 kBChecksumma SHA-512
2cfaf51d7e6fd27396a53f32e1868826337369d11055bfc0aeb0379309a16946207d477045e5a3c399985d378aa9c7173fbc1f88eeb79bbb7423e8e9c10995c4
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Danskog, KatarinaFrängsmyr, LarsBecker, MiriamLenman, AnnasaraArnberg, Niklas

Sök vidare i DiVA

Av författaren/redaktören
Danskog, KatarinaFrängsmyr, LarsBecker, MiriamLenman, AnnasaraArnberg, Niklas
Av organisationen
Institutionen för klinisk mikrobiologiWallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)Umeå Centre for Microbial Research (UCMR)Molekylär Infektionsmedicin, Sverige (MIMS)
I samma tidskrift
mBio
Mikrobiologi inom det medicinska områdetMedicinsk bioteknologi (Inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)

Sök vidare utanför DiVA

GoogleGoogle Scholar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 511 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf